Jim Simons Biogen Inc. Transaction History

Renaissance Technologies LLC

$63.6 Billion
Q1 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Biogen Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 884,704 shares of BIIB stock, worth $199 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

884,704

Previous 758,606 16.62%

Holding current value

$199 Million

Previous $196 Million 2.82%

% of portfolio

0.3%

Previous 0.3%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$212.02 - $267.71 $26.7 Million - $33.8 Million	126,098 Added 16.62%	884,704 $191 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $73 Million - $87.8 Million	-327,791 Reduced 30.17%	758,606 $196 Million
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $5.86 Million - $6.62 Million	-23,140 Reduced 2.09%	1,086,397 $279 Million
Q2 2023 Aug 11, 2023	SELL	$275.25 - $318.06 $42.5 Million - $49.1 Million	-154,300 Reduced 12.21%	1,109,537 $316 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $67.6 Million - $77 Million	263,561 Added 26.35%	1,263,837 $351 Million

Q4 2022 Feb 13, 2023	SELL	$252.44 - $306.72 $38.9 Million - $47.3 Million	-154,231 Reduced 13.36%	1,000,276 $277 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $76.2 Million - $105 Million	-391,500 Reduced 25.32%	1,154,507 $308 Million
Q2 2022 Aug 12, 2022	BUY	$187.54 - $223.02 $94.1 Million - $112 Million	501,800 Added 48.06%	1,546,007 $315 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $5.74 Million - $7.23 Million	-29,600 Reduced 2.76%	1,044,207 $220 Million
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $20.6 Million - $26.5 Million	92,100 Added 9.38%	1,073,807 $258 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $98.6 Million - $129 Million	-348,296 Reduced 26.19%	981,707 $278 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $158 Million - $252 Million	-608,159 Reduced 31.38%	1,330,003 $461 Million
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $267 Million - $313 Million	-1,099,600 Reduced 36.2%	1,938,162 $542 Million
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $184 Million - $277 Million	-779,199 Reduced 20.41%	3,037,762 $744 Million
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $23.6 Million - $27.2 Million	-88,961 Reduced 2.28%	3,816,961 $1.08 Billion
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $147 Million - $195 Million	-567,990 Reduced 12.7%	3,905,922 $1.05 Billion
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $25.8 Million - $32.7 Million	-95,994 Reduced 2.1%	4,473,912 $1.42 Billion
Q4 2019 Feb 13, 2020	BUY	$220.06 - $304.07 $76.7 Million - $106 Million	348,700 Added 8.26%	4,569,906 $1.36 Billion
Q3 2019 Nov 13, 2019	BUY	$217.44 - $243.88 $378 Million - $424 Million	1,738,129 Added 70.0%	4,221,206 $983 Million
Q2 2019 Aug 12, 2019	BUY	$219.29 - $241.72 $187 Million - $206 Million	851,263 Added 52.17%	2,483,077 $581 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $134 Million - $209 Million	617,100 Added 60.82%	1,631,814 $386 Million
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $283 Million - $358 Million	1,014,714 New	1,014,714 $305 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account